CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Feb. 28, 2014	Nov. 30, 2013
Current assets
Cash and cash equivalents	$ 240,965	$ 146,205
Other current assets	25,274	32,600
Total current assets	266,239	178,805
Property and equipment, net of accumulated depreciation of $40,561	0	0
Other assets	280	280
Total assets	266,519	179,085
Current liabilities
Accounts payable and accrued expenses	1,138,229	1,072,521
Payable to related party	50,000	50,000
Advance from warrant holder	138,545	61,950
Convertible debentures	0	45,146
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,376,092	1,278,935
Non-current liabilities
Convertible debentures	43,076	0
Deferred revenue, net of current portion	437,094	449,424
Derivative liability related to Series B convertible preferred stock	25,406	18,147
Total non-current liabilities	505,576	467,571
Total liabilities	1,881,668	1,746,506
Commitments and contingencies	0	0
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	0	0
Common stock, $0.01 par value; 5,000,000,000 shares authorized; 3,152,360,170 and 2,610,793,503 shares issued and outstanding at February 28, 2014 and November 30, 2013, respectively	31,523,602	26,107,935
Additional paid-in capital	11,409,060	16,556,524
Accumulated deficit	(43,769,469)	(43,489,211)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(374,972)	(362,917)
Noncontrolling interests	(1,240,177)	(1,204,504)
Total equity (deficiency)	(1,615,149)	(1,567,421)
Total liabilities and equity (deficiency)	266,519	179,085
Series B Convertible Preferred Stock [Member]
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	461,835	461,835
Series I Convertible Preferred Stock [Member]
MultiCell Technologies, Inc. equity (deficiency)
Preferred stock	$ 0	$ 0